A bill co-sponsored by Senator Chuck Grassley, R-Iowa, and Senator Amy Klobuchar, D-Minnesota, would allow people to buy prescription drugs from approved pharmacies in Canada; the FDA is planning an advisory meeting on February 12 to share evidence and expert opinion about the safety and effectiveness of transvaginal mesh; economist Austin Frakt recaps the public health effects of sitting in traffic, including contributing to climate change, lost time, and damage to psychological well-being.
A bill co-sponsored by Senator Chuck Grassley, R-Iowa, and Senator Amy Klobuchar, D-Minnesota, would allow people to buy prescription drugs from approved pharmacies in Canada. The bill is reigniting a long-simmering debate about drug importation, a proposal strongly opposed by the powerful pharmaceutical lobby, as well as giving Republicans an early test on their commitment to lowering drug prices, The Hill reported.The FDA is planning an advisory meeting on February 12 to share evidence and expert opinion about the safety and effectiveness of transvaginal mesh, according to The Washington Post, which reported on the health problems and resulting lawsuits brought by women who have had surgery for urinary incontinence and prolapse. About 3 million to 4 million women worldwide have had mesh implanted, and about 5% have had complications, which are difficult or impossible to fix, according to some doctors.A column in The New York Times by economist Austin Frakt recaps the public health effects of sitting in traffic, including contributing to climate change, lost time, and damage to psychological well-being. The total cost of traffic exceeds $100 billion per year, he wrote.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More
Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age
March 28th 2024A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Read More